MNKD — MANNKIND CORP

Ownership history in Frazier Life Sciences Management, L.P.  ·  1 quarter on record

This page tracks every 13F SEC filing in which Frazier Life Sciences Management, L.P. reported a position in MANNKIND CORP (MNKD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.64% (2025 Q4)
Avg. % of fund
0.64%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 4,225,000 — — 0.64% $24.0M $5.67
% of Fund (quarterly)    MNKD price (monthly, adj. close)

Other funds also holding MNKD

As of 2025 Q4 — sorted by position size

Nitorum Capital, L.P. 3Y 7Y 6.68% TSP Capital Management Group, LLC 3Y 7Y 4.11% 180 WEALTH ADVISORS, LLC 3Y 7Y 1.91% APIS CAPITAL ADVISORS, LLC 3Y 7Y 1.19% 1492 Capital Management LLC 3Y 7Y 1.16% DELTEC ASSET MANAGEMENT LLC 3Y 7Y 0.92% SCOPIA CAPITAL MANAGEMENT LP 3Y 7Y 0.81% Eversept Partners, LP 3Y 7Y 0.53% Rubric Capital Management LP 3Y 7Y 0.51% Bayesian Capital Management, LP 3Y 7Y 0.46%
← Back to Frazier Life Sciences Management, L.P. Holdings